Dr. Jason Luke on Utilizing the Tumor Microenvironment as a Biomarker for Immunotherapy Response
November 20th 2015
Jason Luke, MD, Assistant Professor of Medicine, the University of Chicago Medicine Comprehensive Cancer Center, discusses how inflammation in the tumor microenvironment can serve as a biomarker in melanoma.